Trials / Sponsors / Lallemand Pharma AG
Lallemand Pharma AG
Industry · 9 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Prevention With Healsea in Adults Against Respiratory Infection Study Healthy Subjects (HS) | N/A | 2024-11-29 |
| Completed | HEALSea Nasal Spray for Prevention of Infections in Children Healthy Subjects | Phase 2 / Phase 3 | 2024-11-25 |
| Completed | Survey of Incidence of Respiratory Tract Infections Healthy Adults, Not Healthy Adults | — | 2023-11-07 |
| Completed | BАbykids Spray In Common Cold Common Cold, Rhinitis Viral | N/A | 2023-02-13 |
| Completed | Testing the Efficacy in Adults With Cold of HEalsea Rescue* Common Cold | N/A | 2022-12-14 |
| Completed | Impact of Symbiofilm On Nasal Microbiota Rhinosinusitis Chronic, Microbiome | — | 2022-12-12 |
| Completed | Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK) Common Cold, Allergy | — | 2022-02-14 |
| Completed | Efficacy Of Bacterial Lysate In Asthmatic Children Allergic Asthma | Phase 3 | 2014-07-01 |
| Completed | Advanced Immunological Approach in COPD Exacerbation Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | 2009-09-01 |